Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Association between the affordable care act and mortality after STEMI (age < 65). by Laurent G. Glance (9914864)

Association between the affordable care act and revascularization after STEMI (age < 65). by Laurent G. Glance (9914864)

Association between medicaid expansion and mortality after STEMI (age < 65). by Laurent G. Glance (9914864)

Association between the affordable care act and disparities in revascularization after STEMI (age < 65). by Laurent G. Glance (9914864)

Association between medicaid expansion and disparities in revascularization after STEMI (age < 65). by Laurent G. Glance (9914864)

A compilation of results from microarray analyses of temporal expression of Notch, WNT, and circadian genes in the somites [34] and suprachiasmatic nucleus, liver, and heart [35],... by Kristen L. Curran (95520)

Evolution of resource intensity with different technology level parameter <i>a</i>₄. by Xinghua Fan (7344632)

Participants characteristics. by Sakiko Fukui (387048)

Supplementary Material for: TNFAIP2 Inhibits Early TNFa-Induced NF-κB Signaling and Decreases Survival in Septic Shock Patients by Thair S.A. (4152325)

VLS#3 treatment attenuates the age-related decrease in LTP and the age-related increase in microglial activation. by Eleonora Distrutti (134147)

Losartan decreases vessel size but not effect microvessel density or pericyte recruitment in Pan02 tumors grown in <i>SPARC−/−</i> animals. by Shanna A. Arnold (183991)

Subcutaneous injections of IL-2 decrease PD-1 expression in CD4+ and CD8+ T cells. by Vedran Brezar (337452)

EGCG3”Me treatment could sharply decrease the formation of antiparallel β-sheets in diabtetic kidneys. by Shuxian Cai (464566)

Time-dependent decrease of H₂ content in each drinking water and their pH. by Kyota Fujita (258978)

Annual decrease in the risk of first, second, and third hospital admission after the age of 60, for men and women. by Korinna Karampampa (574815)

Effects of FSH on PKAI, and decrease in PKAI regulatory subunit (RIα) levels after activation of PKAI. by Junxia Li (136291)